News
Ultragenyx Releases Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
Ultragenyx Pharmaceutical Inc. released its 2025 Impact Report, detailing the company's work on behalf of patients and families living with rare and ultra-rare diseases. In 2025, Ultragenyx advanced five investigational therapies in pivotal clinical programs with the potential to reach tens of thousands of patients around the world — while continuing to build on years of work to support patients who cannot yet access approved treatments, which have now reached individuals in 50 countries.“The rare disease
.png)
Brick Marketing Adds Client Case Studies Highlighting Real Digital Marketing Results
BOSTON, May 5, 2026 — Brick Marketing today announced the addition of new client case studies that showcase real outcomes achieved for B2B and B2C organizations across a wide range of industries. The expanded collection highlights how strategic marketing leadership and customized execution have helped companies reach business sales and marketing goals through search engine optimization, AI search or Generative Engine Optimization, content marketing, social media management, PPC advertising, and related
